168 related articles for article (PubMed ID: 31933908)
1. Differential expression of HSP90 isoforms and their correlations with clinicopathologic factors in patients with colorectal cancer.
Kim K; Lee HW; Lee EH; Park MI; Lee JS; Kim MS; Kim K; Roh MS; Pak MG; Oh JE; Kim KM; Lee JW; Kim TG; Nam HY
Int J Clin Exp Pathol; 2019; 12(3):978-986. PubMed ID: 31933908
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of heat shock protein 90 isoforms in small cell lung cancer.
Lee JH; Kang KW; Kim JE; Hwang SW; Park JH; Kim SH; Ji JH; Kim TG; Nam HY; Roh MS; Lee EH; Park MI; Kim MS; Lee HW
Int J Clin Exp Pathol; 2015; 8(8):9487-93. PubMed ID: 26464709
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activities of novel heat shock protein 90 isoform selective inhibitors in BV-2 microglial cells.
Smith AG; Kliebe VM; Mishra S; McCall RP; Irvine MM; Blagg BSJ; Lei W
Front Mol Biosci; 2024; 11():1405339. PubMed ID: 38756532
[TBL] [Abstract][Full Text] [Related]
4. Expressed as the sole Hsp90 of yeast, the alpha and beta isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90beta generates sensitivity to the Hsp90 inhibitor radicicol.
Millson SH; Truman AW; Rácz A; Hu B; Panaretou B; Nuttall J; Mollapour M; Söti C; Piper PW
FEBS J; 2007 Sep; 274(17):4453-63. PubMed ID: 17681020
[TBL] [Abstract][Full Text] [Related]
5. Cytosolic Hsp90α and its mitochondrial isoform Trap1 are differentially required in a breast cancer model.
Vartholomaiou E; Madon-Simon M; Hagmann S; Mühlebach G; Wurst W; Floss T; Picard D
Oncotarget; 2017 Mar; 8(11):17428-17442. PubMed ID: 28407697
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of heat shock protein 90α expression as a biomarker of prognosis in patients with gastric cancer.
Lee HW; Kim KM
Niger J Clin Pract; 2019 Dec; 22(12):1698-1705. PubMed ID: 31793477
[TBL] [Abstract][Full Text] [Related]
7. Organelle-specific Hsp90 inhibitors.
Seo YH
Arch Pharm Res; 2015 Sep; 38(9):1582-90. PubMed ID: 26195286
[TBL] [Abstract][Full Text] [Related]
8. Detecting Posttranslational Modifications of Hsp90 Isoforms.
Sager RA; Backe SJ; Neckers L; Woodford MR; Mollapour M
Methods Mol Biol; 2023; 2693():125-139. PubMed ID: 37540432
[TBL] [Abstract][Full Text] [Related]
9. Blind cavefish and heat shock protein chaperones: a novel role for hsp90alpha in lens apoptosis.
Hooven TA; Yamamoto Y; Jeffery WR
Int J Dev Biol; 2004; 48(8-9):731-8. PubMed ID: 15558465
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of glucose-related protein 94 in colorectal cancer.
Lee JS; Roh MS; Lee HW; Lee EH; Pak MG; Kim K; Nam HY; Kim KM; Jung SB
Pathol Res Pract; 2020 Jul; 216(7):153013. PubMed ID: 32534715
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
Pak MG; Koh HJ; Roh MS
Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
[TBL] [Abstract][Full Text] [Related]
12. Proliferation, migration, and resistance to oxidative and thermal stresses of HT1080 cells with knocked out genes encoding Hsp90α and Hsp90β.
Petrenko V; Vrublevskaya V; Bystrova M; Masulis I; Kopylova E; Skarga Y; Zhmurina M; Morenkov O
Biochem Biophys Res Commun; 2023 Sep; 674():62-68. PubMed ID: 37406487
[TBL] [Abstract][Full Text] [Related]
13. Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases.
Ernst JT; Liu M; Zuccola H; Neubert T; Beaumont K; Turnbull A; Kallel A; Vought B; Stamos D
Bioorg Med Chem Lett; 2014 Jan; 24(1):204-8. PubMed ID: 24332488
[TBL] [Abstract][Full Text] [Related]
14. 5'-N-ethylcarboxamidoadenosine is not a paralog-specific Hsp90 inhibitor.
Liu S; Street TO
Protein Sci; 2016 Dec; 25(12):2209-2215. PubMed ID: 27667530
[TBL] [Abstract][Full Text] [Related]
15. TRAP1: a viable therapeutic target for future cancer treatments?
Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
[TBL] [Abstract][Full Text] [Related]
16. Multiple Targeting of HSP Isoforms to Challenge Isoform Specificity and Compensatory Expression.
Ono K; Eguchi T
Methods Mol Biol; 2023; 2693():141-161. PubMed ID: 37540433
[TBL] [Abstract][Full Text] [Related]
17. NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90.
Huck JD; Que NLS; Immormino RM; Shrestha L; Taldone T; Chiosis G; Gewirth DT
J Biol Chem; 2019 Nov; 294(44):16010-16019. PubMed ID: 31501246
[TBL] [Abstract][Full Text] [Related]
18. Role of HSP90 in Cancer.
Birbo B; Madu EE; Madu CO; Jain A; Lu Y
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638658
[TBL] [Abstract][Full Text] [Related]
19. Radiosynthesis and preclinical evaluation of [
Cools R; Vermeulen K; Narykina V; Leitao RCF; Bormans G
EJNMMI Radiopharm Chem; 2023 Jan; 8(1):2. PubMed ID: 36715827
[TBL] [Abstract][Full Text] [Related]
20. The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep.
Chang C; Tang X; Woodley DT; Chen M; Li W
Cells; 2023 Jan; 12(2):. PubMed ID: 36672211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
